Back to search
13-valent Pneumococcal Vaccine
Clinical trial pipeline · Data from ClinicalTrials.gov
See which 13-valent Pneumococcal Vaccine trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which 13-valent Pneumococcal Vaccine trials you may qualify forThis is a Phase 3 randomized, observation-blinded, active-controlled, parallel-group clinical trial designed to evaluate the immunogenicity, safety, and functio…
A Phase Ⅲ clinical trial of 13-valent pneumococcal conjugate vaccine (PCV13) developed by Sinovac Life Science Co., Ltd will be conducted in pediatric populatio…
The goal of this clinical trial is to evaluate the immunogenicity and safety of Minhai's 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13-DT/TT) a…
This Phase 1, randomized, double-blind, third-party-unblinded study will be conducted at investigational sites in China. The purpose of the study is to learn ab…
The purpose of this study is to evaluate the safety and immunogenicity of Bexsero (meningococcal group B vaccine-rMenB+OMV NZ) in North American infants 6 weeks…